Close

Publications

Gupta, P; PRIETO-MERINO, D; Ajay, VS; Singh, K; Roy, A; Krishnan, A; Narayan, KM V; Ali, MK; Tandon, N; PRABHAKARAN, D; PEREL, P;
2019
Wellcome Open Research, (2019).4 71 10.12688/wellcomeopenres.15137.1.
ADLER, AJ; Laar, A; PRIETO-MERINO, D; Der, RM M; Mangortey, D; Dirks, R; LAMPTEY, P; PEREL, P;
2019
BMJ open, (2019).9 4 10.1136/bmjopen-2018-026799.
Haldane, V; Tan, YG; Teo, KW Q; Koh, JJ K; Srivastava, A; Cheng, RX; Yap, YC; Ong, P-S; Van Dam, RM; Foo, JM; Müller-Riemenschneider, F; Koh, GC-H; PEREL, P; LEGIDO-QUIGLEY, H;
2019
JMIR mHealth and uHealth, (2019).7 3 10.2196/11108.
Carrillo-Larco, RM; Altez-Fernandez, C; Pacheco-Barrios, N; Bambs, C; Irazola, V; MIRANDA, JJ; Danaei, G; PEREL, P;
2019
GLOBAL HEART, (2019).14 1 10.1016/j.gheart.2019.03.001.
Kehlenbrink, S; SMITH, J; ANSBRO, É; FUHR, DC; Cheung, A; RATNAYAKE, R; Boulle, P; Jobanputra, K; PEREL, P; ROBERTS, B;
2019
LANCET DIABETES & ENDOCRINOLOGY, (2019).7 8 10.1016/S2213-8587(19)30082-8.
Who makes the decision to receive Oxaliplatin among stage III colorectal cancer (CRC) patients?.
HASSAN, S; Miles, A; MORRIS, M;
2019
PSYCHO-ONCOLOGY, (2019).28,
BENITEZ MAJANO, S; Di Girolamo, C; RACHET, B; MARINGE, C; Guren, MG; Glimelius, B; Iversen, LH; Schnell, EA; Lundqvist, K; Christensen, J; MORRIS, M; COLEMAN, MP; WALTERS, S;
2018
The Lancet Oncology, (2018).20 1 10.1016/S1470-2045(18)30646-6.
MUDIE, K; Jin, MM; Tan,; Kendall, L; Addo, J; DOS-SANTOS-SILVA, I; Quint, J; SMEETH, L; COOK, S; NITSCH, D; Natamba, B; Gomez-Olive, FX; Ako, A; PEREL, P;
2018
Journal of global health, (2018).9 2 10.7189/jogh.09.020409.
Thomas, H; Diamond, J; Vieco, A; Chaudhuri, S; Shinnar, E; Cromer, S; PEREL, P; Mensah, GA; Narula, J; Johnson, CO; Roth, GA; Moran, AE;
2018
Global heart, (2018).13 3 10.1016/j.gheart.2018.09.511.
BENITEZ MAJANO, S; VANSTEELANDT, S; Di Girolamo, C; MORRIS, M; WALTERS, S; RACHET, B;
2018
Annals of oncology : official journal of the European Society for Medical Oncology, (2018).29 Suppl 8, 10.1093/annonc/mdy297.027.